Injection site reactions, including bruising, are documented adverse effects in semaglutide clinical trials, though bruising is not separately reported in FDA labeling
The team developed a high-specificity mass spectrometry assay that detects only the bioactive form of GLP-1 -- the version that actually stimulates insulin -- not the inactive fragments that often muddy results
QUALITY & SAFETY: Produced in a cGMP (Good Manufacturing Practices) facility and aggressively tested for safety
A researcher who genuinely wanted to study a mechanism angiogenesis, collagen synthesis, anti-inflammatory signaling would be far better served by single, well-characterized peptides at known concentrations than by a proprietary blend of uncertain composition
Verywell Health Key takeaways ADA 2025 supports CGM broadly, with expanded consideration for adults with type 2 diabetes beyond insulin
Anetta Reszko, MD, is a clinical assistant professor of dermatology at Weill Cornell Medical College and an Assistant Attending Dermatologist at New York Presbyterian Hospital